Systemic pain relief after omalizumab injection in patient with hypermobile Ehlers –Danlos syndrome: A case report

Symptomatology pre and post Omalizumab treatment. Key Clinical MessageOmalizumab may be a beneficial adjunct treatment option for hEDS patients require to improve pain control, ability to perform ADLs and functionality and social engagement, and most importantly, quality of life.

Source: Clinical Case Reports - January 12, 2024 Category: General Medicine Authors: Sarahrose Jonik, Andrew Joseph Rothka, Neyha Cherin Tags: CASE REPORT Source Type: research